Skip to content
Open access

Unsupervised Machine Learning of Automated Brain Volumetry Uncovers Three Volumetric Endophenotypes in Cognitive Impair-ment

Jul 2026 · Balneo and PRM Research Journal · Vol 17 · 0 citations · 31 references

TL;DR

The findings suggest that cognitive impairment manifests through heterogeneous patterns of structural brain involvement, with potential implications for prognosis and personalized care, and the high accuracy of a parsimonious four-feature model supports the clinical utility of focused volumetric assessment for risk stratification.

Abstract

Cognitive impairment and dementia represent a heterogeneous group of disorders with variable patterns of brain atrophy. Automated brain volumetry combined with machine learning offers the potential to identify biologically meaningful subgroups beyond traditional clinical classifications. This study aimed to characterize cerebral volumetric profiles and identify distinct volumetric endophenotypes in individuals with cognitive impairment using unsupervised machine learning. This retrospective cross-sectional study included 78 participants with cognitive impairment who underwent T1-weighted three-dimensional magnetic resonance imaging (MRI). Automated brain volumetry was performed using mdbrain software (version 2.2), which provides normalized percentile values for 42 brain regions adjusted for age, sex, and total intracranial volume. Unsupervised k-means clustering was applied to volumetric percentiles to identify distinct endophenotypes. Cluster validation was performed using elbow method, silhouette analysis, Calinski-Harabasz index, and Davies-Bouldin index. Discriminative features were identified using ANOVA with effect size calculations (η²). A multinomial logistic regression model was developed to predict cluster membership. The cohort comprised 48 (61.5%) females and 30 (38.5%) males. Substantial inter-individual variability was observed across all brain regions, with hippocampal percentiles ranging from 0.1 to 99.8 (median: 25.6). Clustering analysis revealed three distinct volumetric endophenotypes: Cluster 1 (Preserved, n=27, 34.6%) characterized by percentiles above the 40th percentile; Cluster 2 (Moderate Atrophy, n=31, 39.7%) with percentiles in the 10th–30th range; and Cluster 3 (Severe Atrophy, n=20, 25.6%) with hippocampal percentiles below the 5th percentile and ventricular percentiles above the 85th percentile. Hippocampal volumes demonstrated the strongest discriminative ability (left hippocampus: F=68.4, η²=0.64; right hippocampus: F=65.2, η²=0.63), followed by temporal (η²=0.60–0.61) and ventricular volumes (η²=0.57–0.58). Interhemispheric asymmetry was minimal (median absolute difference: 3.4–7.2 percentile points). A parsimonious model using four volumetric features (left hippocampus, left temporal, left ventricle, and right frontal percentiles) achieved excellent classification accuracy (87.2%, cross-validated AUC=0.91). Automated brain volumetry combined with unsupervised machine learning identified three distinct volumetric endophenotypes in cognitive impairment, primarily discriminated by hippocampal, temporal, and ventricular volumes. These findings suggest that cognitive impairment manifests through heterogeneous patterns of structural brain involvement, with potential implications for prognosis and personalized care. The high accuracy of a parsimonious four-feature model supports the clinical utility of focused volumetric assessment for risk stratification. Future longitudinal studies with multimodal biomarker integration are warranted to validate these findings and establish their prognostic value.

Read PDF

Similar papers

Open access Sep 2026

FastSurfer-Based Brain Morphometry and Machine-Learning Classification Across the Alzheimer’s Disease Spectrum

Background: This study aimed to quantitatively assess structural changes in the hippocampus, amygdala, entorhinal cortex, lateral ventricles, precuneus, and posterior cingulate using deep-learning-based FastSurfer morphometry and evaluate their contribution to classification across the Alzheimer’s disease (AD) spectrum...

Sinem Nur Altun, Hürriyet Çetinok · 0 citations
Open access Sep 2026

Machine learning-derived Alzheimer’s disease dimensions: neuroanatomical, cognitive, clinical, functional, and genetic risk heterogeneity signatures

Alzheimer's disease (AD) is characterized by substantial clinical and biological heterogeneity, with diverse neuroanatomical, cognitive, clinical, functional, and genetic risk profiles that are poorly captured by current diagnostic frameworks. Identifying reproducible disease dimensions is critical for understanding di...

Hoang-Bach-Dat Le, S. Ishrat, B. Yaghooti et al. · 0 citations
Open access Aug 2026

Sex-Specific Regional Brain Morphometric Correlates of Neighborhood Socioeconomic Disadvantage in Clinical Neuroimaging

BACKGROUND AND PURPOSE Neighborhood-level socioeconomic disadvantage is associated with adverse brain morphometry, yet whether these associations differ by biological sex remain opaque. Here, we investigated sex-specific associations between the area deprivation index and brain morphometry derived from routine clinical...

Ethan H. Willbrand, Luis Vázquez, Michael B. Fromandi et al. · 0 citations
Open access Sep 2026

Development and Validation of An Explainable Artificial Intelligence–Driven Structural Brain Health and Neurodegenerative Risk Index Using Automated Mri Volumetry, Cortical Thickness, Brain Age Prediction, Network-Based Biomarkers, And Hemispheric Asymmet

Background: Artificial intelligence (AI)-based volumetric analysis has transformed structural brain MRI by enabling automated quantification of hundreds of cortical and subcortical anatomical parameters. Although numerous regional biomarkers have been proposed, current approaches rely predominantly on isolated volumetr...

Gadekar Shubham Adinath, S. Sachin, G. Yuvabalakumaran et al. · 0 citations
Open access Sep 2026

A Machine Learning Framework for Binary and Multiclass Classification of Cognitive Impairment Using Structural MRI Biomarkers

IntroductionAlzheimer’s disease (AD) is the leading cause of dementia worldwide and is characterized by progressive decline in cognitive functions. Mild Cognitive Impairment (MCI) represents an intermediate stage between normal aging and dementia, with measurable cognitive decline but largely preserved functional indep...

Alessia Venuto, Ambra Faraci, Alessandro Grimaldi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.